The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objective Administration of glucagon (GCG) or GCG-containing co-agonists reduces body weight and increases energy expenditure. These actions appear to be transduced by multiple direct and indirect GCG receptor (GCGR)-dependent mechanisms. Although the canonical GCGR is expressed in brown adipose tissue (BAT) the importance of BAT GCGR activity for the physiological control of body weight, or the response to GCG agonism, has not been defined. Methods We studied the mechanisms linking GCG action to acute increases in oxygen consumption using wildtype (WT), Ucp1 −/− and Fgf21 −/− mice. The importance of basal GCGR expression within the Myf5 + domain for control of body weight, adiposity, glucose and lipid metabolism, food intake, and energy expenditure was examined in Gcgr BAT−/− mice housed at room temperature or 4 °C, fed a regular chow diet (RCD) or after a prolonged exposure to high fat diet (HFD). Results Acute GCG administration induced lipolysis and increased the expression of thermogenic genes in BAT cells, whereas knockdown of Gcgr reduced expression of genes related to thermogenesis. GCG increased energy expenditure (measured by oxygen consumption) both in vivo in WT mice and ex vivo in BAT and liver explants. GCG also increased acute energy expenditure in Ucp1 −/− mice, but these actions were partially blunted in Ffg21 −/− mice. However, acute GCG administration also robustly increased oxygen consumption in Gcgr BAT−/− mice. Moreover, body weight, glycemia, lipid metabolism, body temperature, food intake, activity, energy expenditure and adipose tissue gene expression profiles were normal in Gcgr BAT−/− mice, either on RCD or HFD, whether studied at room temperature, or chronically housed at 4 °C. Conclusions Exogenous GCG increases oxygen consumption in mice, also evident both in liver and BAT explants ex vivo , through UCP1-independent, FGF21-dependent pathways. Nevertheless, GCGR signaling within BAT is not physiologically essential for control of body weight, whole body energy expenditure, glucose homeostasis, or the adaptive metabolic response to cold or prolonged exposure to an energy dense diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Finan, B., Yang, B., Ottaway, N., Smiley, D. L., Ma, T., Clemmensen, C., Chabenne, J., Zhang, L., Habegger, K. M., Fischer, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3761 · Cited by 645
Self-citationA new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641
Self-citationPhysiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498 · cited 1×
“The proglucagon-derived peptides (PGDPs) are encoded by a single mammalian gene and include glucagon (GCG), oxyntomodulin, glicentin, and two GCG-like peptides, GLP-1 and GLP-2 [1].”
BackgroundThe New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419 · cited 3×
“Identification of the key tissues essential for the GCGR-dependent control of energy expenditure remains incomplete, and the available evidence supports a role for multiple organs, including liver and adipose tissue, in transducing GCGR-stimulated signals linked to enhanced oxygen consumption [3,32].”
BackgroundThe metabolic actions of glucagon revisited
Habegger, K. M., Heppner, K. M., Geary, N., Bartness, T. J., DiMarchi, R., & Tschöp, M. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.187 · Cited by 406
Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
Habegger, K. M., Stemmer, K., Cheng, C., Müller, T. D., Heppner, K. M., Ottaway, N., Holland, J., Hembree, J. L., Smiley, D., Gelfanov, V., et al. (2013) · Diabetes · doi:10.2337/db12-1116 · Cited by 245
Henderson, S. J., Konkar, A., Hornigold, D. C., Trevaskis, J. L., Jackson, R., Fritsch Fredin, M., Jansson‐Löfmark, R., Naylor, J., Rossi, A., Bednarek, M. A., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12735 · Cited by 240
Effect of glucagon on the metabolism of adipose tissue
Hagen, J. H. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64236-x · Cited by 212
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
Salem, V., Izzi‐Engbeaya, C., Coello, C., Thomas, D. B., Chambers, E. S., Comninos, A. N., Buckley, A., Win, Z., Al‐Nahhas, A., Rabiner, E. A., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12585 · Cited by 167
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
Capozzi, M. E., DiMarchi, R. D., Tschöp, M. H., Finan, B., & Campbell, J. E. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00117 · Cited by 153 · cited 1×
“The clinical development of investigational GCG-containing multi-agonists, including oxyntomodulin and its derivatives [3,24,25], for the treatment of diabetes and obesity has rekindled interest in whether and how GCGR signaling results in BAT activation and increased energy expenditure [2,26,27].”
BackgroundSelf-citation
Research works printed but not linked: 31
- Campbell, 2015, Islet alpha cells and glucagon–critical regulators of energy homeostasis, Nature Reviews Endocrinology, 11, 329, 10.1038/nrendo.2015.51 · DOI · Paper page
- Jelinek, 1993, Expression cloning and signaling properties of the rat glucagon receptor, Science, 259, 1614, 10.1126/science.8384375 · DOI · Paper page
- Campos, 1994, Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse, Endocrinology, 1342156
- Svoboda, 1994, Relative quantitative analysis of glucagon receptor mRNA in rat tissues, Molecular and Cellular Endocrinology, 105, 131, 10.1016/0303-7207(94)90162-7 · DOI
- Steinberg, 1964, Effects of the prostaglandins on hormone-induced mobilization of free fatty acids, Journal of Clinical Investigation, 431533
- Richter, 1989, Human glucagon and vasoactive intestinal polypeptide (VIP) stimulate free fatty acid release from human adipose tissue in vitro, Peptides, 10, 333, 10.1016/0196-9781(89)90039-9 · DOI
- Joel, 1966, Stimulation of metabolism of rat brown adipose tissue by addition of lipolytic hormones in vitro, Journal of Biological Chemistry, 241, 814, 10.1016/S0021-9258(18)96838-9 · DOI · Paper page
- Townsend, 2019, Loss of glucagon signaling alters white adipose tissue browning, The FASEB Journal, 10.1096/fj.201802048RR · DOI · Paper page
- Davidson, 1960, The effect of glucagon on the metabolic rate of rats, American Journal of Clinical Nutrition, 8, 540, 10.1093/ajcn/8.5.540 · DOI
- Heim, 1966, The effect of propranalol on the calorigenic response in brown adipose tissue of new-born rabbits to catecholamines, glucagon, corticotrophin and cold exposure, Journal of Physiology, 187, 271, 10.1113/jphysiol.1966.sp008088 · DOI · Paper page
- Schulman, 1957, Effect of glucagon on food intake and body weight in man, Journal of Applied Physiology, 11, 419, 10.1152/jappl.1957.11.3.419 · DOI · Paper page
- Geary, 1992, Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men, American Journal of Physiology, 262, R975
- Leichter, 1980, Clinical and metabolic aspects of glucagonoma, Medicine (Baltimore), 59, 100, 10.1097/00005792-198003000-00002 · doi:10.1097/00005792-198003000-00002
- Inokuchi, 1984, Effect of intracerebroventricularly infused glucagon on feeding behavior, Physiology & Behavior, 33, 397, 10.1016/0031-9384(84)90160-4 · DOI
- Atrens, 1993, Glucagon and the paraventricular hypothalamus: modulation of energy balance, Brain Research, 630, 245, 10.1016/0006-8993(93)90663-8 · DOI
- Billington, 1987, Glucagon stimulation of brown adipose tissue growth and thermogenesis, American Journal of Physiology, 252, R160
- Tschop, 2016, Unimolecular polypharmacy for treatment of diabetes and obesity, Cell Metabolism, 24, 51, 10.1016/j.cmet.2016.06.021 · DOI · Paper page
- Heppner, 2010, Glucagon regulation of energy metabolism, Physiology & Behavior, 100, 545, 10.1016/j.physbeh.2010.03.019 · DOI
- Yahata, 1983, Effects of glucagon and noradrenaline on the blood flow through brown adipose tissue in temperature-acclimated rats, The Japanese Journal of Physiology, 33, 367, 10.2170/jjphysiol.33.367 · DOI · Paper page
- Dicker, 1998, Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells, American Journal of Physiology, 275, R1674
- Filali-Zegzouti, 2005, Role of catecholamines in glucagon-induced thermogenesis, Journal of Neural Transmission, 112, 481, 10.1007/s00702-004-0199-7 · DOI
- Kim, 2018, Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21, Diabetes, 67, 1773, 10.2337/db17-1502 · DOI · Paper page
- Kuroshima, 1979, Thermogenic responses of brown adipocytes to noradrenaline and glucagon in heat-acclimated and cold-acclimated rats, The Japanese Journal of Physiology, 29, 683, 10.2170/jjphysiol.29.683 · DOI · Paper page
- Svendsen, 2018, Insulin secretion depends on intra-islet glucagon signaling, Cell Reports, 25, 1127, 10.1016/j.celrep.2018.10.018 · DOI · Paper page
- Longuet, 2013, Liver-specific disruption of the murine glucagon receptor produces alpha-cell hyperplasia: evidence for a circulating alpha-cell growth factor, Diabetes, 62, 1196, 10.2337/db11-1605 · DOI · Paper page
- Panaro, 2019, Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice, Molecular Metabolism, 1965
- Uldry, 2006, Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation, Cell Metabolism, 3, 333, 10.1016/j.cmet.2006.04.002 · DOI · Paper page
- Arafat, 2013, Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?, Diabetologia, 56, 588, 10.1007/s00125-012-2803-y · DOI
- Doi, 1982, Thermogenic response to glucagon in cold-acclimated mice, The Japanese Journal of Physiology, 32, 377, 10.2170/jjphysiol.32.377 · DOI
- Howland, 1987, Modulation by insulin and glucagon of noradrenaline-induced activation of isolated brown adipocytes from the rat, European Journal of Biochemistry, 169, 155, 10.1111/j.1432-1033.1987.tb13593.x · DOI
- Kinoshita, 2014, Glucagon is essential for adaptive thermogenesis in brown adipose tissue, Endocrinology, 155, 3484, 10.1210/en.2014-1175 · DOI · Paper page
Cited by
GLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510
Self-citationThe role of adipokines in health and disease
Clemente-Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., Martínez-Guardado, I., Navarro-Jiménez, E., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2023) · Biomedicines · doi:10.3390/biomedicines11051290 · Cited by 463
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease.
Baggio, L. L., & Drucker, D. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101090 · Cited by 299
“also increases energy expenditure and brown adipose tissue (BAT) activity in mice [46], actions that are partially diminished in Fgf21 / mice [46]; however, whether glucagon promotes meaningful BAT activity in humans is less clear [47].”
BackgroundResultSelf-citationMoiz, A., Filion, K. B., Tsoukas, M. A., Yu, O. H., Peters, T. M., & Eisenberg, M. J. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.01.021 · Cited by 241
Glucagon Regulation of Energy Expenditure
Kleinert, M., Sachs, S., Habegger, K. M., Hofmann, S. M., & Müller, T. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215407 · Cited by 147
Metadata
- Authors
- Beaudry, J. L., Kaur, K. D., Varin, E. M., Baggio, L. L., Cao, X., Mulvihill, E. E., Stern, J. H., Campbell, J. E., Scherer, P. E., & Drucker, D. J.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 22
- Pages
- 37-48
- ISSN
- 2212-8778 (ISSN-L)
- OpenAlex
- W2911794357
- Cited by
- 88
- References
- 13
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Novo Nordisk
- Canadian Diabetes Association
- Shire
- Diabetes Canada
- National Institutes of Health (P01-AG051459, P01-DK088761, R00AG055649, R01-DK099110, R01-DK55758)
- Merck Canada
- Zafgen
- Eli Lilly and Company
- Canadian Institutes of Health Research (154321)
- Novo Nordisk UK Research Foundation
- Merck
- Pfizer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice. https://app.cochat.ai/papers/10.1016/j.molmet.2019.01.011
- The paper
- Beaudry, J. L., Kaur, K. D., Varin, E. M., Baggio, L. L., Cao, X., Mulvihill, E. E., Stern, J. H., Campbell, J. E., Scherer, P. E., & Drucker, D. J. (2019). The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice. Molecular Metabolism. https://doi.org/10.1016/j.molmet.2019.01.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.